Suraksha诊断计划启动一个IPO,目的是在12月6日提高846卢比和清单。 Suraksha Diagnostic plans to launch an IPO, aiming to raise Rs 846 crore and list on December 6.

以加尔各答为基地的Suraksha诊断系统是印度东部一个主要的诊断链,计划于11月29日启动其846克鲁格的IPO。 Kolkata-based Suraksha Diagnostic, a leading diagnostic chain in eastern India, plans to launch its Rs 846-crore IPO on November 29. IPO涉及出售19,189,330股,没有新发行的股票,价格在420卢比至441卢比之间。 The IPO involves the sale of 19,189,330 shares without a fresh issue, priced between Rs 420 and Rs 441. 股份分配给符合条件的机构买家(50%)、零售投资者(35%)和非机构投资者(15%)。 Shares are allocated to qualified institutional buyers (50%), retail investors (35%), and non-institutional investors (15%). 该公司在西孟加拉邦、比哈尔、阿萨姆和梅加拉亚开展业务,报告在24财政年度有219卢比的收入,并打算在12月6日列入BSE和NSE。 The company, with operations in West Bengal, Bihar, Assam, and Meghalaya, reported a revenue of Rs 219 crore in FY24 and aims to list on BSE and NSE on December 6.